- ÀÛ¼ºÀÚ
- °ü¸®ÀÚ
- ÀÛ¼ºÀÏ
- 2022-04-08
- Á¶È¸
- 1835
2022 ¼ºÀα޼º¸²ÇÁ¸ð±¸¹éÇ÷º´ ¿¬±¸È¸ Ãá°è ½ÉÆ÷Áö¾ö
¾È³çÇϽʴϱî?
´Ù°¡¿À´Â 4¿ù 16ÀÏ Åä¿äÀÏ, ºÎ»ê º¤½ºÄÚ¿¡¼ 2022¼ºÀα޼º¸²ÇÁ¸ð±¸¹éÇ÷º´ Ãá°è½ÉÆ÷Áö¾öÀÌ °³ÃÖµÉ ¿¹Á¤ÀÔ´Ï´Ù.
À̹ø ½ÉÆ÷Áö¾ö¿¡¼´Â 2021³â ÁøÇàµÇ¾ú´ø ASH annual meeting ¿¡¼ update µÈ ³»¿ëµéÀ» Á¤¸®Çϰí,
ÃÖ±Ù ALL °ü·Ã Hot topic ÀÎ MRD ¿Í T-cell engineering ¿¡ ´ëÇÑ ³»¿ëµéÀ» ´Ù·ç°íÀÚ ÇÕ´Ï´Ù.
¶ÇÇÑ, ±Ý³â ½ÉÆ÷Áö¾öºÎÅÍ´Â ALL °ú °ü·ÃµÈ ´Ù±â°ü Àӻ󿬱¸¸¦ Ȱ¼ºÈ ½Ã۰íÀÚ »õ·Î¿î ¿¬±¸ Á¦¾ÈÀ» ¹Þ°íÀÚ ÇÕ´Ï´Ù.
ÀüÇ⿬±¸, ÈÄÇ⿬±¸ »ó°ü¾øÀÌ ÁÁÀº ¾ÆÀ̵ð¾î°¡ ÀÖÀ¸½Å ºÐµéÀ» ºÎ´ã¾øÀÌ ¾Æ·¡ ¸ÞÀÏ·Î ÀǰßÁÖ½Ã¸é °¨»çÇϰڽÀ´Ï´Ù.
½ÉÆ÷Áö¾ö °ü·Ã ÀÚ¼¼ÇÑ ³»¿ëÀº ¾Æ·¡ ÀÏÁ¤Ç¥¸¦ Âü°íÇØÁÖ½Ã°í ¿¬ÀÚ°¡ È®Á¤µÇ´Â ´ë·Î Ãß°¡ ¾È³»µå¸®µµ·Ï ÇϰڽÀ´Ï´Ù.
Âü¼®À» ¿øÇϽô ºÐµé²²¼´Â ¾Æ·¡ »çÀüµî·Ï ¸µÅ©¸¦ ÀÌ¿ëÇØ µî·Ï ºÎʵ右´Ï´Ù. °¨»çÇÕ´Ï´Ù.
¼ºÀα޼º¸²ÇÁ¸ð±¸¹éÇ÷º´¿¬±¸È¸ À§¿øÀå ½ÅÈ£Áø/°£»ç ±è´ë½Ä
‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒
ÀϽÃ: 2022³â 4¿ù 16ÀÏ (Åä) 10:00 – 16:00
Àå¼Ò: ºÎ»ê, º¤½ºÄÚ Á¦1ȸÀÇÀå 214È£-218È£
¿¬¼ö ÆòÁ¡: ´ëÇÑÀÇ»çÇùȸ 4ÆòÁ¡, ´ëÇѳ»°úÇÐȸ Ç÷¾×Á¾¾ç³»°ú ºÐ°úÀü¹®ÀÇ 4ÆòÁ¡
µî·Ïºñ: ¹«·á (¼÷¹Ú Áö¿ø)
¼÷¹Ú: ¼¾ÅÒÇÁ¸®¹Ì¾î È£ÅÚ (15ÀÏ, ±Ý¿äÀÏ 1¹Ú Áö¿ø)
»çÀüµî·Ï ¸¶°¨: 2022³â 4¿ù 9ÀÏ
Session 1: Update on ALL 2022 (°æºÏÀÇ´ë ¹®ÁØÈ£)
10:00-10:30 B-ALL: Updated practices (ÀÎÁ¦ÀÇ´ë ÀÓ¼º³²)
10:30-11:00 T-ALL: Updated practices (¾ÆÁÖÀÇ´ë ÃÖÀ±¼®)
11:00-11:30 Pathophysiology and biomarkers in ALL (¿ï»êÀÇ´ë ±è¹Ì¿µ)
11:30-12:00 Novel therapeutics in ALL (including preclinical) (°è¸íÀÇ´ë Çã¹ÌÈ)
12:00-13:00: Lunch
Session 2: Hot topics in ALL (ºÎ»êÀÇ´ë ½ÅÈ£Áø)
13:00-14:00 Newest technology in T-cell engineering for lymphoid malignancy
(Çѱ¹°úÇбâ¼ú¿ø ±èÂùÇõ)
14:00-14:30 Insights on minimal residual disease measurement (°¡Å縯ÀÇ´ë ¾È¾Æ¸®)
14:30-15:00 MRD based ALL treatment (¼¿ïÀÇ´ë °í¿µÀÏ)
15:00-15:10 Break
Session3: KALLWP Àӻ󿬱¸Á¦¾È (¼¿ïÀÇ´ë °í¿µÀÏ)
15:10-16:00: Current status and new proposals
‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒
»çÀüµî·Ï: http://naver.me/FaZkZe1h ·Î »çÀüµî·Ï ºÎʵ右´Ï´Ù.
¿¬±¸Á¦¾È ¸ÞÀÏÁÖ¼Ò: kay9801@naver.com, Àû±ØÀûÀÎ ¿¬±¸ Á¦¾È ºÎʵ右´Ï´Ù.